Pharmacokinetics of interleukin-6 during therapy with anti-interleukin-6 monoclonal antibodies: enhanced clearance of interleukin-6 by a combination of three anti-interleukin-6 antibodies.
Montero-Julian
F A
FA
Immunotech S.A., Marseilles, France.
Gautherot
E
E
Wijdenes
J
J
Klein
B
B
Brailly
H
H
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology / Q000493:pharmacokinetics*; D008657:Metabolic Clearance Rate / Q000276:immunology; D009101:Multiple Myeloma / Q000628:therapy*
D000911:Antibodies, Monoclonal; D015850:Interleukin-6